Search result for 'torrent pharma'

Torrent Group completes acquisition of a majority stake in IPL franchise Gujarat Titans, marking its entry into the Indian sports sector. The deal includes CVC retaining a minority stake.

Torrent Pharmaceuticals reported a 17% rise in consolidated profit after tax to Rs 453 crore in Q2 FY24, driven by strong domestic sales. Revenue also increased to Rs 2,889 crore.

Torrent Pharmaceuticals received a demand notice of Rs 6.32 lakh from the NPPA for launching a new drug without prior price approval. The NPPA enforces drug pricing regulations in India.

The Indian Pharmaceutical Alliance (IPA) expresses concern over linking spurious drugs with legitimate manufacturers, emphasizing severe reputational and financial consequences. The organization...

Leading pharma companies like Sun Pharma and Torrent Pharma have denied manufacturing drugs flagged by CDSCO as 'not of standard quality', claiming they are counterfeits.

Torrent Pharmaceuticals received a Form 483 with one observation from the USFDA after an inspection of its Pithampur manufacturing facility. The observation is procedural in nature and the company...

Torrent Pharma's Q1 PAT surged 21% to Rs 457 crore, driven by strong domestic performance. Revenue also grew to Rs 2,859 crore. Read more.

Torrent Pharmaceuticals received a Form 483 with five observations from the USFDA after an inspection of its Gujarat manufacturing plant. The company will respond to the observations within the...

Torrent Pharmaceuticals has licensed Vonoprazan, a novel P-CAB for GERD treatment, from Takeda. The drug will be marketed in India under the brand name Kabvie.

The Indian rupee appreciated by 4 paise to 83.06 against the US dollar on Monday, tracking positive domestic equities and a weaker US dollar. Read more.

Torrent Pharmaceuticals Ltd reported a 56.45% jump in consolidated net profit to Rs 449 crore in the March quarter, driven by higher revenue. The company's India, Brazil and Germany businesses saw...

Cipla promoters offload 2.53% stake for Rs 2,750 crore to create liquidity for philanthropy and other needs. The deal was completed through a block deal on the NSE, with buyers including Aditya...

Torrent Pharmaceuticals reported a 52% jump in its consolidated profit after tax to Rs 443 crore in the third quarter ended December 2023, driven by strong domestic and international growth.

USFDA issued Form 483 with 5 procedural observations to Torrent Pharma's Gujarat oral manufacturing facility. The observations were not related to data integrity.